These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 3477409)

  • 21. In vitro activity, pharmacokinetics, clinical safety and therapeutic efficacy of enoxacin in the treatment of patients with complicated urinary tract infections.
    Naber KG; Sörgel F; Gutzler F; Bartosik-Wich B
    Infection; 1985; 13(5):219-24. PubMed ID: 2933340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic determination of relative potency of quinolone inhibition of caffeine disposition.
    Barnett G; Segura J; de la Torre R; Carbó M
    Eur J Clin Pharmacol; 1990; 39(1):63-9. PubMed ID: 2177401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Gyrase inhibitors modify metabolising processes in the liver].
    Staib AH; Harder S; Papenburg A; Stille W
    Dtsch Med Wochenschr; 1987 Oct; 112(44):1720-1. PubMed ID: 2822371
    [No Abstract]   [Full Text] [Related]  

  • 24. Influence of ofloxacin, norfloxacin, nalidixic acid, pyromidic acid and pipemidic acid on human gamma-interferon production and blastogenesis.
    De Simone C; Baldinelli L; Ferrazzi M; De Santis S; Pugnaloni L; Sorice F
    J Antimicrob Chemother; 1986 Jun; 17(6):811-4. PubMed ID: 3090010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
    O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(4):253-7. PubMed ID: 2941257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative pharmacokinetics of theophylline following two fluoroquinolones co-administration.
    Sano M; Yamamoto I; Ueda J; Yoshikawa E; Yamashina H; Goto M
    Eur J Clin Pharmacol; 1987; 32(4):431-2. PubMed ID: 3475207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of enoxacin, ofloxacin and norfloxacin on theophylline disposition in humans.
    Sano M; Kawakatsu K; Ohkita C; Yamamoto I; Takeyama M; Yamashina H; Goto M
    Eur J Clin Pharmacol; 1988; 35(2):161-5. PubMed ID: 3191935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative pharmacokinetics of new quinolones.
    Lode H; Höffken G; Prinzing C; Glatzel P; Wiley R; Olschewski P; Sievers B; Reimnitz D; Borner K; Koeppe P
    Drugs; 1987; 34 Suppl 1():21-5. PubMed ID: 3481323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative in-vitro activity of five fluoroquinolones against mycobacteria.
    Davies S; Sparham PD; Spencer RC
    J Antimicrob Chemother; 1987 May; 19(5):605-9. PubMed ID: 3112094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of quinolone derivatives on theophylline clearance.
    Wijnands WJ; Vree TB; van Herwaarden CL
    Br J Clin Pharmacol; 1986 Dec; 22(6):677-83. PubMed ID: 3567014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of quinolones with the theophylline metabolism in man: investigations with lomefloxacin and pipemidic acid.
    Staib AH; Harder S; Fuhr U; Wack C
    Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):289-3. PubMed ID: 2737798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [In vitro antibacterial activity of new derivatives of pyridonecarboxylic acid, norfloxacin, ofloxacin, enoxacin and ciprofloxacin, against Vibrio cholerae O-1].
    Matsushita S; Yamada S; Kudoh Y; Ohashi M
    Kansenshogaku Zasshi; 1987 Mar; 61(3):292-6. PubMed ID: 3112282
    [No Abstract]   [Full Text] [Related]  

  • 33. In vitro and in vivo activity of NY-198, a new difluorinated quinolone.
    Hirose T; Okezaki E; Kato H; Ito Y; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1987 Jun; 31(6):854-9. PubMed ID: 3476021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates.
    Periti P; Mazzei T; Nicoletti P
    Chemioterapia; 1987 Apr; 6(2):75-8. PubMed ID: 3474081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of plasmid conjugation by some recently synthetized 4-quinolone compounds.
    Scazzocchio F; Selan L; Oliva B; Schippa S; Cellini L; Renzini G
    Chemioterapia; 1988 Oct; 7(5):295-7. PubMed ID: 3066516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quinolones.
    Shah PM
    Prog Drug Res; 1987; 31():243-56. PubMed ID: 3326031
    [No Abstract]   [Full Text] [Related]  

  • 37. Activity of five fluoroquinolones against Mycobacterium avium-intracellulare complex and M. xenopi.
    Rastogi N; Goh KS; David HL
    Ann Inst Pasteur Microbiol; 1988; 139(2):233-7. PubMed ID: 3165641
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparative bactericidal kinetics of ciprofloxacin, ofloxacin and pefloxacin alone and in combination against strains of group D Streptococcus].
    Zuccarelli M; Simeon de Buochberg M; Maillols M; Armynot du Chatelet AM; Attisso MA
    Pathol Biol (Paris); 1988 May; 36(5):403-9. PubMed ID: 3136422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapeutic contribution of the new quinolones].
    Wolff M
    Rev Prat; 1987 Apr; 37(21):1209-14. PubMed ID: 3474759
    [No Abstract]   [Full Text] [Related]  

  • 40. Interaction between the fluoroquinolones and the bronchodilator theophylline.
    Wijnands WJ; Vree TB
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():109-14. PubMed ID: 3053575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.